Xeris Chairman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

News Category Global Banking & Finance Reviews
Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection
Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced it was granted Fast Track designation by the Food and Drug Administration (FDA) for the investigation of XP-0863 (diazepam non-aqueous injection) for the treatment of acute repetitive seizures. Xeris XP-0863 was previously granted orphan designations both for the treatment of acute repetitive seizures and for the treatment of Dravet Syndrome. ....

United States , Allison Wey , Gvoke Hypopen , Paulr Edick , Exchange Commission , Xeris Pharmaceuticals Inc , Corporate Communications , Drug Administration , Xeris Pharmaceuticals , Fast Track , Xeris Chairman , Chief Executive , Private Securities Litigation Reform Act , Quarterly Report , Vice President , Investor Relations , ஒன்றுபட்டது மாநிலங்களில் , அல்லிசன் வெய் , பரிமாற்றம் தரகு , பெருநிறுவன தகவல்தொடர்புகள் , வேகமாக டிராக் , தலைமை நிர்வாகி , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , காலாண்டு அறிக்கை , துணை ப்ரெஸிடெஂட் , முதலீட்டாளர் உறவுகள் ,